January 2023: In This Issue

As “therapeutic orphans,” pregnant women and their health care providers must balance the benefits of treatment with the risk of fetal harm.

Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.

A study found that a continuous glucose monitor workflow led by a pharmacist led to reduced HbA1c levels.

Drug Topics discussed independent pharmacy advocacy and PBM reform on the state level with Miguel Rodriguez, Executive Vice President and general counsel for American Pharmacies.

A conversation with AJ Loiacono, co-founder and CEO of Capital RX, at NCPA 2024.

Researchers compared the racial and ethnic representation of participants in food allergen trials with patients who experience food allergies.